Multimarker Approach to Identify Patients with Coronary Artery Disease at High Risk for Subsequent Cardiac Adverse...

Area of Science:

• Cardiology
• Biomarker Discovery
• Predictive Analytics

Background:

• Coronary artery disease (CAD) poses a significant risk for adverse cardiac events (AE).
• Accurate prediction of AE is crucial for timely intervention and personalized treatment strategies.
• Existing risk stratification models may not fully capture the dynamic nature of CAD progression.

Purpose of the Study:

• To evaluate a multimarker approach for predicting subsequent cardiac adverse events in CAD patients.
• To assess the combined discriminatory predictive value of seven specific biomarkers.
• To compare the predictive performance of canonical discriminant analysis with traditional logistic regression.

Main Methods:

• Prospective, non-randomized, single-center cohort study with 161 patients.
• Evaluation of seven biomarkers: S100A12, IL1R4, adrenomedullin, copeptin, NGAL, suPAR, and IMA.
• Primary endpoint assessed using canonical discriminant function analysis for AE prediction over 1-year follow-up.

Main Results:

• Canonical discriminant analysis yielded a significant predictive model (Wilk's lambda = 0.78, p < 0.001).
• The multimarker model achieved 79.4% sensitivity and 74.3% specificity in predicting AE.
• The developed model demonstrated superior predictive performance compared to traditional logistic regression models.

Conclusions:

• Canonical discriminant analysis of a multimarker panel effectively predicts cardiac adverse events in CAD patients.
• This approach allows for defining individual patient risk thresholds, facilitating personalized medicine.
• The findings support the integration of these biomarkers into clinical practice for enhanced risk stratification.